vs
KINGSTONE COMPANIES, INC.（KINS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是KINGSTONE COMPANIES, INC.的1.3倍（$75.5M vs $56.4M），KINGSTONE COMPANIES, INC.同比增速更快（34.0% vs 27.7%），KINGSTONE COMPANIES, INC.自由现金流更多（$73.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 25.6%）
金斯顿公司总部位于纽约金斯顿，核心业务通过旗下金斯顿保险公司开展财产意外保险产品服务，同时旗下持纽约州牌照的保险保费融资公司Payments, Inc.，会与第三方持牌保费融资机构签订合作协议。在2010年专业保险代理人协会的企业绩效调查中，金斯顿保险公司在81家参评保险公司中排名第一。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KINS vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$56.4M
营收增速更快
KINS
高出6.3%
27.7%
自由现金流更多
KINS
多$58.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
25.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.4M | $75.5M |
| 净利润 | $14.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 32.7% | 22.7% |
| 净利率 | 26.2% | — |
| 营收同比 | 34.0% | 27.7% |
| 净利润同比 | 171.4% | — |
| 每股收益（稀释后） | $1.09 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KINSPBYI
| Q4 25 | $56.4M | $75.5M | ||
| Q3 25 | $55.7M | $54.5M | ||
| Q2 25 | $52.3M | $52.4M | ||
| Q1 25 | $50.5M | $46.0M | ||
| Q4 24 | $42.1M | $59.1M | ||
| Q3 24 | $40.8M | $80.5M | ||
| Q2 24 | $36.5M | $47.1M | ||
| Q1 24 | $35.8M | $43.8M |
净利润KINSPBYI
| Q4 25 | $14.8M | — | ||
| Q3 25 | $10.9M | $8.8M | ||
| Q2 25 | $11.3M | $5.9M | ||
| Q1 25 | $3.9M | $3.0M | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $7.0M | $20.3M | ||
| Q2 24 | $4.5M | $-4.5M | ||
| Q1 24 | $1.4M | $-4.8M |
毛利率KINSPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率KINSPBYI
| Q4 25 | 32.7% | 22.7% | ||
| Q3 25 | 24.6% | 17.6% | ||
| Q2 25 | 27.1% | 12.7% | ||
| Q1 25 | 9.3% | 8.7% | ||
| Q4 24 | 15.9% | 22.6% | ||
| Q3 24 | 22.3% | 27.4% | ||
| Q2 24 | 15.7% | -4.6% | ||
| Q1 24 | 5.0% | -5.3% |
净利率KINSPBYI
| Q4 25 | 26.2% | — | ||
| Q3 25 | 19.5% | 16.2% | ||
| Q2 25 | 21.5% | 11.2% | ||
| Q1 25 | 7.7% | 6.5% | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 17.1% | 25.2% | ||
| Q2 24 | 12.4% | -9.6% | ||
| Q1 24 | 4.0% | -11.0% |
每股收益（稀释后）KINSPBYI
| Q4 25 | $1.09 | $0.26 | ||
| Q3 25 | $0.74 | $0.17 | ||
| Q2 25 | $0.78 | $0.12 | ||
| Q1 25 | $0.27 | $0.06 | ||
| Q4 24 | $0.44 | $0.40 | ||
| Q3 24 | $0.55 | $0.41 | ||
| Q2 24 | $0.37 | $-0.09 | ||
| Q1 24 | $0.12 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $4.4M | $22.7M |
| 股东权益账面价值 | $122.7M | $130.3M |
| 总资产 | $453.4M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.04× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KINSPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务KINSPBYI
| Q4 25 | $4.4M | $22.7M | ||
| Q3 25 | $4.8M | $34.0M | ||
| Q2 25 | $5.1M | $45.3M | ||
| Q1 25 | $5.4M | $56.7M | ||
| Q4 24 | $11.2M | $68.0M | ||
| Q3 24 | $17.3M | $79.3M | ||
| Q2 24 | $25.3M | $90.7M | ||
| Q1 24 | $25.3M | $102.0M |
股东权益KINSPBYI
| Q4 25 | $122.7M | $130.3M | ||
| Q3 25 | $107.7M | $115.3M | ||
| Q2 25 | $94.9M | $104.7M | ||
| Q1 25 | $82.2M | $97.1M | ||
| Q4 24 | $66.7M | $92.1M | ||
| Q3 24 | $59.7M | $71.1M | ||
| Q2 24 | $40.8M | $48.5M | ||
| Q1 24 | $35.7M | $51.0M |
总资产KINSPBYI
| Q4 25 | $453.4M | $216.3M | ||
| Q3 25 | $428.6M | $202.9M | ||
| Q2 25 | $393.4M | $194.9M | ||
| Q1 25 | $385.4M | $196.2M | ||
| Q4 24 | $374.9M | $213.3M | ||
| Q3 24 | $347.0M | $220.7M | ||
| Q2 24 | $319.8M | $205.0M | ||
| Q1 24 | $318.3M | $214.1M |
负债/权益比KINSPBYI
| Q4 25 | 0.04× | 0.17× | ||
| Q3 25 | 0.04× | 0.30× | ||
| Q2 25 | 0.05× | 0.43× | ||
| Q1 25 | 0.07× | 0.58× | ||
| Q4 24 | 0.17× | 0.74× | ||
| Q3 24 | 0.29× | 1.12× | ||
| Q2 24 | 0.62× | 1.87× | ||
| Q1 24 | 0.71× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $73.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 129.5% | 19.1% |
| 资本支出强度资本支出/营收 | 5.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 5.14× | — |
| 过去12个月自由现金流最近4个季度 | $124.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流KINSPBYI
| Q4 25 | $75.9M | $14.4M | ||
| Q3 25 | $25.9M | $9.7M | ||
| Q2 25 | $9.3M | $14.1M | ||
| Q1 25 | $17.9M | $3.6M | ||
| Q4 24 | $57.9M | $15.6M | ||
| Q3 24 | $21.7M | $11.0M | ||
| Q2 24 | $7.1M | $1.0M | ||
| Q1 24 | $6.1M | $11.2M |
自由现金流KINSPBYI
| Q4 25 | $73.1M | $14.4M | ||
| Q3 25 | $25.3M | $9.7M | ||
| Q2 25 | $8.7M | $14.1M | ||
| Q1 25 | $17.0M | $3.6M | ||
| Q4 24 | $55.6M | $15.6M | ||
| Q3 24 | $21.0M | $11.0M | ||
| Q2 24 | $6.6M | $1.0M | ||
| Q1 24 | $5.6M | — |
自由现金流率KINSPBYI
| Q4 25 | 129.5% | 19.1% | ||
| Q3 25 | 45.4% | 17.7% | ||
| Q2 25 | 16.6% | 26.8% | ||
| Q1 25 | 33.7% | 7.7% | ||
| Q4 24 | 132.1% | 26.4% | ||
| Q3 24 | 51.6% | 13.7% | ||
| Q2 24 | 18.1% | 2.1% | ||
| Q1 24 | 15.5% | — |
资本支出强度KINSPBYI
| Q4 25 | 5.0% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 5.6% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.5% | 0.0% |
现金转化率KINSPBYI
| Q4 25 | 5.14× | — | ||
| Q3 25 | 2.38× | 1.10× | ||
| Q2 25 | 0.82× | 2.41× | ||
| Q1 25 | 4.60× | 1.21× | ||
| Q4 24 | 10.65× | — | ||
| Q3 24 | 3.12× | 0.54× | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
